Back
KalVista Pharmaceuticals Vs. Electromed Industry Stock Comparison
Sell
48
KALV
KalVista Pharmaceuticals
Last Price:
9.82
Seasonality Move:
3.67%
Buy
95
ELMD
Electromed
Last Price:
28.75
Seasonality Move:
12.05%
Sell
48
KalVista Pharmaceuticals (KALV)
is a Sell
Is KalVista Pharmaceuticals a Buy, Sell or Hold?
- The current KalVista Pharmaceuticals [KALV] share price is $10.45. The Score for KALV is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- KALV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
95
Electromed (ELMD)
is a Buy
Is Electromed a Buy, Sell or Hold?
- The current Electromed [ELMD] share price is $27.79. The Score for ELMD is 95, which is 90% above its historic median score of 50, and infers lower risk than normal.
- ELMD is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
KALV Stock Price Chart
What is KalVista Pharmaceuticals's stock price today?
-
The KalVista Pharmaceuticals share price today is $10.45
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing selling pressure, which indicates risk of future bearish movement.
ELMD Stock Price Chart
What is Electromed's stock price today?
-
The Electromed share price today is $27.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ELMD is experiencing slight selling pressure.
KALV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 40.61 | Sell |
| Chaikin Money Flow: | -296427 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.91 - 12.13) | Sell |
| Bollinger Bands (100): | (10.9 - 13.5) | Sell |
ELMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.39 | Buy |
| Relative Strength Index (14 RSI): | 78.9 | Buy |
| Chaikin Money Flow: | -87519 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.09 - 25.01) | Buy |
| Bollinger Bands (100): | (14.59 - 22.07) | Buy |
KALV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.14 | Sell |
| 20-day SMA: | 11.51 | Sell |
| 50-day SMA: | 11.33 | Sell |
| 200-day SMA: | 12.34 | Sell |
| 8-day EMA: | 10.99 | Sell |
| 20-day EMA: | 11.26 | Sell |
| 50-day EMA: | 11.54 | Sell |
| 200-day EMA: | 11.78 | Sell |
ELMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.1 | Buy |
| 20-day SMA: | 23.81 | Buy |
| 50-day SMA: | 21.57 | Buy |
| 200-day SMA: | 16.75 | Buy |
| 8-day EMA: | 25.58 | Buy |
| 20-day EMA: | 24.09 | Buy |
| 50-day EMA: | 21.83 | Buy |
| 200-day EMA: | 17.24 | Buy |
KalVista Pharmaceuticals Earnings Growth & KALV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.07 per share.
Electromed Earnings Growth & ELMD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
KalVista Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Electromed Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||